Orforglipron vs Wegovy vs Mounjaro: Which Weight Loss Treatment Is Best?

Orforglipron vs Wegovy vs Mounjaro: Which Weight Loss Treatment Is Best?

Prescription weight loss medications have transformed obesity treatment, offering clinically proven solutions that help people lose significant amounts of weight while improving obesity-related health conditions.

Until recently, most effective GLP-1 medications required injections. However, the emergence of Orforglipron, a once-daily oral tablet, is changing the landscape once again.

Patients now have three leading options to consider:

• Orforglipron – the new once-daily oral GLP-1 tablet.

• Wegovy® (semaglutide) – available as a weekly injection and, following approval, an oral tablet in some markets.

• Mounjaro® (tirzepatide) – a once-weekly dual hormone injection.

Each treatment has unique advantages, different dosing schedules and varying levels of weight loss demonstrated in clinical trials.

In this guide, we'll compare Orforglipron vs Wegovy vs Mounjaro, helping you understand which treatment may be the best fit for your lifestyle, weight loss goals and medical needs.

At a Glance Comparison

How Do These Medications Work?

Although each medication helps reduce appetite, they do so slightly differently.

Orforglipron

Orforglipron is a non-peptide GLP-1 receptor agonist.

It mimics the body's natural GLP-1 hormone to:

• Reduce hunger

• Increase feelings of fullness

• Slow stomach emptying

• Reduce food cravings

Unlike oral semaglutide, it has been developed to offer greater flexibility, with no requirement for fasting before taking the tablet in clinical trials.

Wegovy (Semaglutide)

Wegovy contains semaglutide, a GLP-1 receptor agonist with one of the largest evidence bases in obesity treatment.

It works by:

• Suppressing appetite

• Helping patients feel fuller sooner

• Reducing calorie intake

• Supporting long-term behavioural changes

Semaglutide has also been licensed in certain patient groups to reduce the risk of major cardiovascular events and is approved for adolescents aged 12 years and over with obesity, making it a well-established treatment beyond weight loss alone.

Mounjaro (Tirzepatide)

Mounjaro contains tirzepatide, the first medication to target both:

• GLP-1 receptors

• GIP receptors

By acting on two hormone pathways, it provides powerful appetite suppression and improved blood sugar regulation, contributing to the impressive weight loss seen in clinical studies.

Which Medication Produces the Greatest Weight Loss?

This is one of the most common questions patients ask.

Clinical trial data show that all three medications can produce meaningful weight loss, but average results differ.

*Average weight loss reported in major clinical trials when combined with dietary changes and increased physical activity. Individual results vary.

What Do These Results Mean?

Mounjaro currently demonstrates the highest average weight loss in clinical studies.

Wegovy remains one of the most extensively researched obesity treatments available, with robust evidence supporting long-term weight loss and additional cardiovascular benefits.

Orforglipron offers slightly lower average weight loss than injectable therapies but introduces a significant advantage: highly effective treatment without injections.

Dosing Schedules Compared

All three medications require gradual dose escalation to reduce the risk of digestive side effects.

Orforglipron Dosing

Although the final UK prescribing information will determine the licensed schedule, clinical trials have evaluated:

Treatment is taken once daily.

Wegovy Dosing

The injectable Wegovy schedule gradually increases over 16 weeks:

For oral semaglutide formulations approved for obesity, dosing follows the licensed prescribing information for that product.

Mounjaro Dosing

Mounjaro also uses gradual dose escalation:

Your prescriber will determine the most appropriate maintenance dose based on your response and tolerability.

Why Are the Doses Increased Gradually?

GLP-1 medications slow stomach emptying and alter appetite signals.

Starting immediately on the highest dose would significantly increase the likelihood of side effects.

Gradual dose escalation helps:

• Reduce nausea

• Minimise vomiting

• Improve treatment tolerance

• Increase long-term adherence

• Allow the digestive system to adapt

It is important never to increase your dose faster than advised by your healthcare professional.

Which Treatment Is Most Convenient?

Orforglipron

Pros

• No injections

• No refrigeration

• Once-daily tablet

• Greater flexibility around food intake (based on clinical trial data)

• Easy to travel with

Cons

• Must remember to take a tablet every day

Wegovy

Pros

• Extensive long-term clinical evidence

• Weekly injection (or oral formulation where available)

• Approved for adolescents aged 12+ with obesity

• Licensed cardiovascular risk reduction in eligible adults

• Proven long-term safety profile

Cons

• Injectable version requires weekly injections

• Oral formulations may have specific administration instructions

Mounjaro

Pros

• Highest average weight loss demonstrated

• Weekly injection

• Excellent appetite suppression

• Dual hormone mechanism

Cons

• Injection required

• Refrigeration before first use

• May cause more gastrointestinal side effects during dose escalation

Side Effects

All three medications have similar side effect profiles because they affect the digestive system.

Common side effects include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Bloating

• Indigestion

• Reduced appetite

These symptoms are usually temporary and improve as your body adjusts.

Eating smaller meals, avoiding high-fat foods and staying hydrated may help minimise symptoms.

Which Medication Is Right for You?

The "best" medication depends on your individual circumstances.

Orforglipron may be suitable if you:

• Prefer tablets over injections

• Travel frequently

• Want a convenient daily treatment

• Dislike needles

Wegovy may be suitable if you:

• Want a treatment with extensive long-term evidence

• Are eligible for its additional cardiovascular indication

• Are an adolescent aged 12 years or older with obesity (where clinically appropriate)

• Prefer a treatment with well-established clinical experience

Mounjaro may be suitable if you:

• Want the highest average weight loss seen in clinical trials

• Are comfortable using weekly injections

• Have significant weight loss goals

• Prefer a once-weekly dosing schedule

There is no single "best" medication for everyone. The most effective treatment is often the one that fits your lifestyle, medical history and ability to remain consistent over the long term.

Lifestyle Still Plays a Vital Role

No prescription weight loss medication is a substitute for healthy habits.

The greatest results are achieved when medication is combined with:

• A balanced, calorie-controlled diet

• Regular physical activity

• Adequate hydration

• Sufficient sleep

• Ongoing clinical support

These lifestyle changes help maximise weight loss and improve long-term maintenance.

How 24 HR Pharmacy Can Help

At 24 HR Pharmacy, we understand that choosing between modern weight loss treatments can feel overwhelming, particularly as new medications continue to become available.

Our experienced healthcare professionals provide personalised assessments to determine which treatment is most appropriate for your individual needs.

Our weight management service includes:

• Online clinical consultations

• Expert prescribing where clinically appropriate

• Dose escalation guidance

• Ongoing treatment reviews

• Advice on managing side effects

• Lifestyle support to complement medication

• Discreet UK-wide delivery

As innovative treatments such as Orforglipron become available, we'll continue to offer evidence-based guidance and personalised care to help patients make informed decisions.

Final Thoughts

Orforglipron, Wegovy and Mounjaro all represent significant advances in the treatment of obesity, but each offers different advantages.

• Mounjaro currently provides the greatest average weight loss in clinical trials.

• Wegovy has one of the strongest evidence bases, with additional approvals for cardiovascular risk reduction in eligible adults and use in adolescents aged 12 years and over with obesity.

• Orforglipron is poised to become a highly convenient needle-free alternative, offering meaningful weight loss in a once-daily tablet.

The right choice will depend on your medical history, treatment goals, preferences and lifestyle.

If you're considering prescription weight-loss medication, the team at 24 HR Pharmacy can help you explore your options, answer your questions, and provide ongoing support throughout your weight-loss journey.